These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 34773750)

  • 21. Clinical diagnostic performance evaluation of five immunoassays for antibodies to SARS-CoV-2 diagnosis in a real-life routine care setting.
    Akyala AI; Awayimbo JR; Ogo AC; Chima NJ; Billyrose OMA; Engom AOG
    Pan Afr Med J; 2021; 39():3. PubMed ID: 34178231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of a Lateral Flow Immunoassay COVIDTECH
    Exinger J; Hartard C; Lafferrière F; Fenninger C; Charbonnière LJ; Jeulin H
    Jpn J Infect Dis; 2022 Jul; 75(4):334-340. PubMed ID: 34980703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Operational characteristics of 30 lateral flow immunoassays used to identify COVID-19 immune response.
    David A; Scott L; Jugwanth S; Gededzha M; Kahamba T; Zwane N; Mampeule N; Sanne I; Stevens W; Mayne ES
    J Immunol Methods; 2021 Sep; 496():113096. PubMed ID: 34242653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analytical performances of five SARS-CoV-2 whole-blood finger-stick IgG-IgM combined antibody rapid tests.
    Péré H; Mboumba Bouassa RS; Tonen-Wolyec S; Podglajen I; Veyer D; Bélec L
    J Virol Methods; 2021 Apr; 290():114067. PubMed ID: 33476707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Multiplex Noninvasive Salivary Antibody Assay for SARS-CoV-2 Infection and Its Application in a Population-Based Survey by Mail.
    Egorov AI; Griffin SM; Fuzawa M; Kobylanski J; Grindstaff R; Padgett W; Simmons S; Hallinger DR; Styles JN; Wickersham L; Sams E; Hudgens E; Wade TJ
    Microbiol Spectr; 2021 Oct; 9(2):e0069321. PubMed ID: 34523986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid and quantitative detection of SARS-CoV-2 IgG antibody in serum using optofluidic point-of-care testing fluorescence biosensor.
    Song D; Liu J; Xu W; Han X; Wang H; Cheng Y; Zhuo Y; Long F
    Talanta; 2021 Dec; 235():122800. PubMed ID: 34517658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Four point-of-care lateral flow immunoassays for diagnosis of COVID-19 and for assessing dynamics of antibody responses to SARS-CoV-2.
    Wu JL; Tseng WP; Lin CH; Lee TF; Chung MY; Huang CH; Chen SY; Hsueh PR; Chen SC
    J Infect; 2020 Sep; 81(3):435-442. PubMed ID: 32553841
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical applications of detecting IgG, IgM or IgA antibody for the diagnosis of COVID-19: A meta-analysis and systematic review.
    Chen M; Qin R; Jiang M; Yang Z; Wen W; Li J
    Int J Infect Dis; 2021 Mar; 104():415-422. PubMed ID: 33450372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation of a new automated chemiluminescent anti-SARS-CoV-2 IgM and IgG antibody assay system detecting both N and S proteins in Japan.
    Yokoyama R; Kurano M; Morita Y; Shimura T; Nakano Y; Qian C; Xia F; He F; Kishi Y; Okada J; Yoshikawa N; Nagura Y; Okazaki H; Moriya K; Seto Y; Kodama T; Yatomi Y
    PLoS One; 2021; 16(3):e0247711. PubMed ID: 33661990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis.
    Li Z; Yi Y; Luo X; Xiong N; Liu Y; Li S; Sun R; Wang Y; Hu B; Chen W; Zhang Y; Wang J; Huang B; Lin Y; Yang J; Cai W; Wang X; Cheng J; Chen Z; Sun K; Pan W; Zhan Z; Chen L; Ye F
    J Med Virol; 2020 Sep; 92(9):1518-1524. PubMed ID: 32104917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simultaneous Detection of SARS-CoV-2 IgG/IgM Antibodies, Using Gold Nanoparticles-Based Lateral Flow Immunoassay.
    Ahmadi A; Mirzaeizadeh Z; Omidfar K
    Monoclon Antib Immunodiagn Immunother; 2021 Oct; 40(5):210-218. PubMed ID: 34678096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic performance of four SARS-CoV-2 antibody assays in patients with COVID-19 or with bacterial and non-SARS-CoV-2 viral respiratory infections.
    Huber T; Steininger P; Irrgang P; Korn K; Tenbusch M; Diesch K; Achenbach S; Kremer AE; Werblow M; Vetter M; Bogdan C; Held J
    Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1983-1997. PubMed ID: 34109500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of a rapid immunochromatographic test with a chemiluminescence immunoassay for detection of anti-SARS-CoV-2 IgM and IgG.
    Gambino CM; Lo Sasso B; Colomba C; Giglio RV; Agnello L; Bivona G; Ciaccio M
    Biochem Med (Zagreb); 2020 Oct; 30(3):030901. PubMed ID: 33071558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of Production Lots of a Rapid Point-of-Care Lateral Flow Serological Test Intended for Identification of IgM and IgG against the N-Terminal Part of the Spike Protein (S1) of SARS-CoV-2.
    Hoffman T; Kolstad L; Rönnberg B; Lundkvist Å
    Viruses; 2021 May; 13(6):. PubMed ID: 34072890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dual lateral flow optical/chemiluminescence immunosensors for the rapid detection of salivary and serum IgA in patients with COVID-19 disease.
    Roda A; Cavalera S; Di Nardo F; Calabria D; Rosati S; Simoni P; Colitti B; Baggiani C; Roda M; Anfossi L
    Biosens Bioelectron; 2021 Jan; 172():112765. PubMed ID: 33126179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent Advances in the Evaluation of Serological Assays for the Diagnosis of SARS-CoV-2 Infection and COVID-19.
    Chiereghin A; Zagari RM; Galli S; Moroni A; Gabrielli L; Venturoli S; Bon I; Rossini G; Saracino IM; Pavoni M; Lafratta S; Deni A; Felici S; Borghi M; Guerra L; Raumer L; Lodi V; Viale P; Attard L; Lazzarotto T;
    Front Public Health; 2020; 8():620222. PubMed ID: 33681115
    [No Abstract]   [Full Text] [Related]  

  • 37. Diagnostic Potential of a Luminex-Based Coronavirus Disease 2019 Suspension Immunoassay (COVID-19 SIA) for the Detection of Antibodies against SARS-CoV-2.
    Hoffman T; Kolstad L; Lindahl JF; Albinsson B; Bergqvist A; Rönnberg B; Lundkvist Å
    Viruses; 2021 May; 13(6):. PubMed ID: 34073484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid response flow cytometric assay for the detection of antibody responses to SARS-CoV-2.
    Lapuente D; Maier C; Irrgang P; Hübner J; Peter AS; Hoffmann M; Ensser A; Ziegler K; Winkler TH; Birkholz T; Kremer AE; Steininger P; Korn K; Neipel F; Überla K; Tenbusch M
    Eur J Clin Microbiol Infect Dis; 2021 Apr; 40(4):751-759. PubMed ID: 33078221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of Three Quantitative Anti-SARS-CoV-2 Antibody Immunoassays.
    Chapuy-Regaud S; Miédougé M; Abravanel F; Da Silva I; Porcheron M; Fillaux J; Diméglio C; Izopet J
    Microbiol Spectr; 2021 Dec; 9(3):e0137621. PubMed ID: 34937195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electrochemical immunosensor with Cu
    Rahmati Z; Roushani M; Hosseini H; Choobin H
    Mikrochim Acta; 2021 Mar; 188(3):105. PubMed ID: 33651173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.